study backs new drug for typhoid in poor countries
a large trial comparing treatments for typhoid has backed the use of gatifloxacin, an antibiotic launched by bristol myers squibb in the united states but withdrawn amid worries about side effects.
http://feeds.reuters.com/~r/reuters/healthnews/~3/sxoxevk7quy/us-typhoid-drugs-idustre73r87j20110428
9238
29 Apr 2011 01:06:32
reuters
health